Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Net Margin: 2010-2025

Historic Net Margin for Niagen Bioscience (NAGE) over the last 14 years, with Sep 2025 value amounting to 13.47%.

  • Niagen Bioscience's Net Margin rose 613.00% to 13.47% in Q3 2025 from the same period last year, while for Sep 2025 it was 16.38%, marking a year-over-year increase of 1476.00%. This contributed to the annual value of 8.58% for FY2024, which is 1449.00% up from last year.
  • Latest data reveals that Niagen Bioscience reported Net Margin of 13.47% as of Q3 2025, which was up 16.14% from 11.60% recorded in Q2 2025.
  • Over the past 5 years, Niagen Bioscience's Net Margin peaked at 24.65% during Q4 2024, and registered a low of -51.17% during Q3 2021.
  • Moreover, its 3-year median value for Net Margin was 0.54% (2023), whereas its average is 4.29%.
  • Its Net Margin has fluctuated over the past 5 years, first slumped by 2,144bps in 2021, then spiked by 3,612bps in 2023.
  • Over the past 5 years, Niagen Bioscience's Net Margin (Quarterly) stood at -29.98% in 2021, then surged by 2,311bps to -6.88% in 2022, then spiked by 742bps to 0.54% in 2023, then skyrocketed by 2,411bps to 24.65% in 2024, then spiked by 613bps to 13.47% in 2025.
  • Its last three reported values are 13.47% in Q3 2025, 11.60% for Q2 2025, and 16.61% during Q1 2025.